This aligns with prior studies showing MTFR2's role in tumor progression, such as in breast cancer and oral squamous cell carcinoma, where it shifts glucose metabolism toward glycolysis to enhance proliferation.[29] In the context of HCC, we focused on MTFR2's function within the stromal TME, particularly in aHSCs. The gene discussed is MTFR2; the disease is breast carcinoma.